-
Product Name
Dacetuzumab reference antibody
- Documents
-
Description
Anti-TNFRSF5 / CD40 Antibody (Dacetuzumab)
-
Tested applications
ELISA
-
Species reactivity
Human TNFRSF5 / CD40
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-TNFRSF5 / CD40 Antibody (dacetuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
SEC-HPLC
The purity of Anti-TNFRSF5 / CD40 Antibody (dacetuzumab) is more than 95%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human TNFRSF5 / CD40 His at 2 ug/mL can bind Anti-TNFRSF5 / CD40 Antibody (dacetuzumab), EC50=0.0092 ug/mL.
Bioactivity: FACS
Human CD40 CHO cells were stained with Anti-TNFRSF5 / CD40 Antibody (dacetuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.7412 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"